Researching Dementia Across Canada

C5R sites are located throughout Canada. To locate individual sites,

The Consortium of Canadian Centres for Clinical Cognitive Research (C5R)

is a not-for-profit research network that facilitates collaboration and partnerships between pharmaceutical companies and Canadian dementia researchers. C5R research sites conduct clinical trials in the desire to research and develop treatments for patients with mild cognitive impairment, Alzheimer’s disease as well as other forms of dementia.

Research Canada Wide

C5R has 26 accredited research sites in Canada and 150+ Investigators. Click here to view C5R locations across Canada.

Interested in joining C5R?

Click here to apply for membership!

Research Capabilities

Some of the capabilities of our research sites include MRI (1.5T, 3.0T, 7.0T, FMRI, MR Spectroscopy), PET, Lumbar Puncture, Cyclotron, and IV/SQ therapies.

We are equipped to undertake any new phase I, II, III or IV clinical trial in preclinical, mild cognitive impairment, and dementia (Alzheimer’s disease, Frontotemporal dementia, Lewy body dementia, Parkinson’s dementia, mixed dementia, and vascular dementia).

Services

C5R is a single point of contact for our network of Clinical Research Centres and Memory Clinics studying and treating dementia in Canada. All clinical trial inquiries should go through our Nova Scotia based headquarters. Please contact williamjagger@c5r.ca. tel: (403)407-1856.